Podcast Episodes

Back to Search
Pharmaceutical Executive Daily: Zentalis Doses First Patient with Azenosertib in Phase III Trial
Pharmaceutical Executive Daily: Zentalis Doses First Patient with Azenosertib in Phase III Trial

In today's Pharmaceutical Executive Daily, Bayer agrees to acquire Perfuse Therapeutics for up to $2.45 billion and Madrigal obtains an exclusive glo…

6 months, 1 week ago

Short Long
View Episode
Pharmaceutical Executive Daily: BioNTech Reports 2026 First Quarter Results
Pharmaceutical Executive Daily: BioNTech Reports 2026 First Quarter Results

In today's Pharmaceutical Executive Daily, Cellenkos announces FDA clearance of its investigational new drug application for CK0802, BioNTech release…

6 months, 1 week ago

Short Long
View Episode
Pharmaceutical Executive Daily: UCB to Acquire Candid Therapeutics
Pharmaceutical Executive Daily: UCB to Acquire Candid Therapeutics

In today's Pharmaceutical Executive Daily, UCB announces a definitive agreement to acquire Candid Therapeutics for up to $2.2 billion, a new commenta…

6 months, 2 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: FDA Approves Auvelity
Pharmaceutical Executive Daily: FDA Approves Auvelity

In today's Pharmaceutical Executive Daily, the FDA's Oncologic Drugs Advisory Committee votes a favorable benefit-risk profile for AstraZeneca's Truq…

6 months, 2 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: Sanofi Appoints Belén Garijo as CEO
Pharmaceutical Executive Daily: Sanofi Appoints Belén Garijo as CEO

In today’s Pharmaceutical Executive Daily, Sanofi formally confirms its CEO leadership following a shareholder vote, US prescription drug spending is…

6 months, 2 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: Rocket Pharmaceuticals Sells Pediatric Disease Priority Review Voucher
Pharmaceutical Executive Daily: Rocket Pharmaceuticals Sells Pediatric Disease Priority Review Voucher

In today's Pharmaceutical Executive Daily, Rocket Pharmaceuticals announces a $180 million sale of its rare pediatric disease priority review voucher…

6 months, 2 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: FDA Approves Breztri
Pharmaceutical Executive Daily: FDA Approves Breztri

In today's Pharmaceutical Executive Daily, we cover Sun Pharma and IMG Pharma's respective acquisitions, FDA's approval of AstraZeneca's Breztri, and…

6 months, 3 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: FDA Approves Caplyta for Adults with Schizophrenia
Pharmaceutical Executive Daily: FDA Approves Caplyta for Adults with Schizophrenia

In today's Pharmaceutical Executive Daily, Eli Lilly announces a definitive agreement to acquire Ajax Therapeutics for up to $2.3 billion, adding a f…

6 months, 3 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: FDA Issues CRL to AbbVie
Pharmaceutical Executive Daily: FDA Issues CRL to AbbVie

In today’s Pharmaceutical Executive Daily, the FDA issues a complete response letter to AbbVie for a biologics license application, Regeneron moves t…

6 months, 3 weeks ago

Short Long
View Episode
Pharmaceutical Executive Daily: FDA Expands Approvals for Tzield and Dupixent
Pharmaceutical Executive Daily: FDA Expands Approvals for Tzield and Dupixent

In today’s Pharmaceutical Executive Daily, the FDA expands the use of Tzield to young children to delay the onset of stage 3 type 1 diabetes, Dupixen…

6 months, 3 weeks ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us